Clinical characteristics of depression in patients with irritable bowel syndrome at Bach Mai hospital, 2025 - 2026
Main Article Content
Abstract
The study aims to describe the clinical characteristics of depression in patients with irritable bowel syndrome at Bach Mai Hospital during 2025 – 2026. A cross-sectional descriptive study on 164 patients showed that the majority were female (64.0%), with a mean age of 49.2 ± 13.8 years old, and the diarrhea-predominant subtype was the most common (66.5%). The prevalence of depression according to ICD-10 was 24.4%, in which the diarrhea subtype had a higher rate compared to other subtypes (30.3%). The main symptoms commonly observed included depressed mood (100%) and reduced energy with increased fatigue (95.0%). Common symptoms included sleep disturbances (77.5%), decreased concentration (65.0%), and appetite alterations (62.5%). A prominent somatic symptom was loss of previous interests and pleasure. The results indicate that depression is a common condition in patients with irritable bowel syndrome, with diverse clinical manifestations in which somatic symptoms predominate, potentially affecting quality of life and treatment outcomes; therefore, early identification and timely intervention are crucial.
Article Details
Keywords
Depression, irritable bowel syndrome
References
2. Oka P, Parr H, Barberio B, et al. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020; 5(10): 908-917. doi:10.1016/S2468-1253(20)30217-X.
3. Schmulson MJ, Drossman DA. What is new in Rome IV. J Neurogastroenterol Motil. 2017; 23(2): 151-163. doi:10.5056/jnm16214
4. Mudyanadzo TA, Hauzaree C, Yerokhina O, Architha NN, Ashqar HM. Irritable bowel syndrome and depression: a shared pathogenesis. Cureus. 2018; 10(8): e3178. doi:10.7759/cureus.3178.
5. Tarar ZI, Farooq U, Zafar Y, et al. Burden of anxiety and depression among hospitalized patients with irritable bowel syndrome: a nationwide analysis. Ir J Med Sci. 2023; 192(5): 2159-2166. doi:10.1007/s11845-022-03258-6.
6. Banerjee A, Sarkhel S, Dhali GK, et al. A follow-up study of anxiety and depressive symptoms in irritable bowel syndrome. Indian J Psychiatry. 2024; 66(2): 142-147. doi:10.4103/indianjpsychiatry.indianjpsychiatry_732_23.
7. Phan Trung Nam, Trần Quốc Khánh. Nghiên cứu rối loạn lo âu, trầm cảm bằng thang điểm HADS ở bệnh nhân hội chứng ruột kích thích. Tạp chí Y Dược học Quân sự. 2023; 48(4): 103-113. doi:10.56535/jmpm.v48i4.318.
8. Zamani M, Alizadeh-Tabari S, Zamani V. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2019; 50(2): 132-143. doi:10.1111/apt.15325.
9. Midenfjord I, Polster A, Sjövall H, et al. Anxiety and depression in irritable bowel syndrome: exploring the interaction with other symptoms and pathophysiology using multivariate analyses. Neurogastroenterol Motil. 2019; 31(8): e13619. doi:10.1111/nmo.13619.
10. Cheng K, Lee C, Garniene R, et al. Epidemiology of irritable bowel syndrome in a large academic safety-net hospital. J Clin Med. 2024;13(5):1314. doi:10.3390/jcm13051314
11. Nguyễn Trường Sơn, Nguyễn Thị Anh Tú, Nguyễn Thị Vân Hồng, Hoàng Mai Hương. Đánh giá chất lượng cuộc sống ở bệnh nhân hội chứng ruột kích thích. Tạp chí Y học Việt Nam. 2022; 511(1). doi:10.51298/vmj.v511i1.2085.
12. Bhinder G, Meza-Cardona JM, Low A, et al. Irritable bowel syndrome patient experience: a survey of patient-reported symptoms by irritable bowel syndrome subtype and impact on quality of life. J Can Assoc Gastroenterol. 2023; 6(6): 219-228. doi:10.1093/jcag/gwad028.
13. Al Shanbari N, Bakry SM, Alzahrani M, et al. Impact of depression on irritable bowel syndrome (IBS)-associated gastrointestinal symptoms: a cross-sectional study in Makkah City, Saudi Arabia. Cureus. 2024; 16(5): e61118. doi:10.7759/cureus.61118.
14. Roohafza H, Bidaki E, Hasanzadeh-Keshteli A, et al. Anxiety, depression and distress among irritable bowel syndrome and their subtypes: an epidemiological population based study. Adv Biomed Res. 2016; 5:183. doi:10.4103/2277-9175.190938.
15. Hu Z, Li M, Yao L, et al. The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis. BMC Gastroenterol. 2021; 21(1): 23. doi:10.1186/s12876-020-01593-5.
16. Zhu F, Tu H, Chen T. The microbiota-gut-brain axis in depression: the potential pathophysiological mechanisms and microbiota combined antidepression effect. Nutrients. 2022;14(10):2081. doi:10.3390/nu14102081.